These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12087032)

  • 1. Fasting hyperglycemia predicts the magnitude of postprandial hyperglycemia: implications for diabetes therapy.
    Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
    Diabetes Care; 2002 Jul; 25(7):1247-8. PubMed ID: 12087032
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of fasting and postprandial hyperglycemia to hemoglobin A1c in insulin-treated Japanese diabetic patients.
    Shimizu H; Uehara Y; Okada S; Mori M
    Endocr J; 2008 Aug; 55(4):753-6. PubMed ID: 18497454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of post-prandial hyperglycemia and its implications.
    Shah SN; Das AK
    J Assoc Physicians India; 2001 Jan; 49 Spec No():1-2. PubMed ID: 11245155
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting prandial hyperglycemia: how important is it and how best to do this?
    Monnier L; Colette C
    Curr Diab Rep; 2008 Oct; 8(5):368-74. PubMed ID: 18778585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial or Fasting Hyperglycemia: Time to Move On?
    DeVries JH
    Diabetes Technol Ther; 2015 Jul; 17(7):441-2. PubMed ID: 26062102
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.
    Woerle HJ; Neumann C; Zschau S; Tenner S; Irsigler A; Schirra J; Gerich JE; Göke B
    Diabetes Res Clin Pract; 2007 Aug; 77(2):280-5. PubMed ID: 17240473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A compensated type 2 diabetic patient? Fasting blood glucose can be deceptive].
    MMW Fortschr Med; 2004 Feb; 146(7):62. PubMed ID: 15347061
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific effect of postprandial glycemic peaks on HBA1c and angiopathy].
    Avignon A; Monnier L
    Diabetes Metab; 2000 Jun; 26 Suppl 2():12-5. PubMed ID: 10975044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1c.
    Kikuchi K; Nezu U; Shirakawa J; Sato K; Togashi Y; Kikuchi T; Aoki K; Ito Y; Kimura M; Terauchi Y
    Endocr J; 2010; 57(3):259-66. PubMed ID: 20086313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postprandial hyperglycemia].
    Perusicová J
    Vnitr Lek; 2003 Dec; 49(12):907-10. PubMed ID: 15040153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
    Giugliano D; Ceriello A; Razzoli E; Esposito K
    Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.
    Fonseca V
    Curr Med Res Opin; 2003; 19(7):635-41. PubMed ID: 14606987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
    Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
    Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining and characterizing the progression of type 2 diabetes.
    Fonseca VA
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S151-6. PubMed ID: 19875543
    [No Abstract]   [Full Text] [Related]  

  • 16. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.
    Esposito K; Giugliano D; Nappo F; Marfella R;
    Circulation; 2004 Jul; 110(2):214-9. PubMed ID: 15197140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Fasting Versus Postprandial Plasma Glucose with HbA1c in Chinese Type 2 Diabetic Patients Taking Different Hypoglycemic Agents.
    Wang X; Wang F; Wang H; Li N
    Clin Lab; 2017 Jul; 63(7):1293-1300. PubMed ID: 28792708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring and natural history of post-prandial hyperglycemia.
    Das AK; Varma RS
    J Assoc Physicians India; 2001 Jan; 49 Spec No():7-10. PubMed ID: 11235609
    [No Abstract]   [Full Text] [Related]  

  • 19. FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED HEMOGLOBIN A1C.
    Shaefer C; Reid T; Vlajnic A; Zhou R; DiGenio A
    Endocr Pract; 2015 Dec; 21(12):1323-32. PubMed ID: 26307902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postprandial glycemia in diabetes patients: assessing this indicator].
    Letonturier P
    Presse Med; 2006 Dec; 35(12 Pt 1):1855-6. PubMed ID: 17205659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.